HomeLPGO • STO
add
Lipigon Pharmaceuticals AB
Previous close
kr 0.11
Day range
kr 0.097 - kr 0.12
Year range
kr 0.090 - kr 0.54
Market cap
15.07M SEK
Avg Volume
638.30K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.14M | 9.78% |
Net income | -6.72M | -38.11% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -6.78M | -18.64% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.74M | -57.43% |
Total assets | 21.03M | -21.72% |
Total liabilities | 2.56M | -38.26% |
Total equity | 18.47M | — |
Shares outstanding | 148.33M | — |
Price to book | 0.88 | — |
Return on assets | -66.08% | — |
Return on capital | -77.60% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -6.72M | -38.11% |
Cash from operations | -8.76M | -210.77% |
Cash from investing | — | — |
Cash from financing | -49.00K | — |
Net change in cash | -8.74M | -210.52% |
Free cash flow | -6.21M | -167.49% |
About
Founded
2010
Website
Employees
6
